HPV prevention and control Board

The HPV prevention and control Board was created in december 2015 with the aim to share relevant information on HPV with a broad array of stakeholders. The HPV prevention and control Board is composed of a group of ‘core’ experts, who set the strategy and define the actions. The HPV Board has a permanent executive secretariat, located at the Vaccine & Infectious Disease Institute (VAXINFECTIO) of the University of Antwerp.

Why a HPV Prevention and Control Board?

With the achievements of decades of work on epidemiology, vaccines and test development, clinical trials, and new screening tools coming into public health and clinical use, the past years have been an exciting time for the Human Papilloma Virus (HPV) prevention community. 

Because of the availability of techniques that facilitate access to prevention, screening and treatment, we believe there is great value added in the establishment of an independent international multidisciplinary HPV prevention and control Board of top experts in the field. Experts who provide evidence based reflection and guidance on strategic, technical, and policy issues that will occur as we move forward in the implementation of our control programs. 

The HPV Board will assist in the monitoring and evaluation of national and regional control programs in support of international organizations such as World Health Organization (WHO), Centre for Disease control (CDC), and Gavi, The Vaccine Alliance.


HPV Prevention and Control Board
Executive Secretariat
University of Antwerp
Campus Drie Eiken - R 2.18
Universiteitsplein 1
2610 Wilrijk
Tel. +32 (0)3 265 26 64
Last update

Last update: 02/10/2017